Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Esperion Therapeutics
Esperion Therapeutics
(ESPR)
Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Nexletol
Bempedoic acid
2020-02-21
2025-2040
Hypercholesterolemia
,
Dyslipidemias
,
Atherosclerosis
,
Hyperlipoproteinemia type ii
,
Familial combined hyperlipidemia
Nexlizet
Bempedoic acid
,
Ezetimibe
2020-02-26
2025-2040
Hypercholesterolemia
,
Dyslipidemias
,
Atherosclerosis
,
Hyperlipoproteinemia type ii
,
Familial combined hyperlipidemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bempedoic acid
type 2 diabetes mellitus
,
diabetes mellitus
,
hypertension
,
hypertriglyceridemia
,
hiv infections
,
inflammation
,
hyperlipidemias
,
hyperlipoproteinemias
,
hypercholesterolemia
,
dyslipidemias
,
cardiovascular diseases
,
atherosclerosis
,
drug-related side effects and adverse reactions
,
st elevation myocardial infarction
,
non-st elevated myocardial infarction
,
myocardial infarction
,
coronary artery disease
,
acute coronary syndrome
,
atherosclerotic plaque
,
metabolic diseases
,
lipid metabolism disorders
,
pregnancy
,
infarction
,
liver diseases
,
non-alcoholic fatty liver disease
,
fatty liver
Ezetimibe
type 2 diabetes mellitus
,
diabetes mellitus
,
hypercholesterolemia
,
hyperlipidemias
,
hyperlipoproteinemias
,
drug-related side effects and adverse reactions
,
atherosclerosis
,
cardiovascular diseases
,
acute coronary syndrome
,
st elevation myocardial infarction
,
non-st elevated myocardial infarction
,
pregnancy
Serine
healthy volunteers/patients
,
pharmacokinetics
,
biological availability
,
prostatic neoplasms
,
medical sociology
,
morbid obesity
,
obesity
,
drug interactions
,
malnutrition
,
disease
,
chronic kidney failure
,
therapeutic equivalency
,
hot flashes
,
non-small-cell lung carcinoma
,
ischemic stroke
,
replacement arthroplasty knee
,
ischemia
,
hemophilia a
,
bariatric surgery
,
transient ischemic attack
,
cerebral infarction
,
venous thrombosis
,
acute coronary syndrome
,
neoplasms
,
surgical blood loss
,
renal insufficiency
,
postoperative hemorrhage
,
infarction
,
heart failure
,
heart diseases
,
rheumatic diseases
,
myocardial infarction
,
myocardial ischemia
,
kidney diseases
,
esophageal neoplasms
,
hematoma
,
respiratory distress syndrome
,
coronavirus infections
,
severe acute respiratory syndrome
,
coronavirus
,
aortic valve stenosis
,
heart valve diseases
,
ventricular outflow obstruction
,
rheumatic heart disease
,
transcatheter aortic valve replacement
,
embolic stroke
,
percutaneous coronary intervention
,
unstable angina
,
knee osteoarthritis
,
hip osteoarthritis
,
arthritis
,
osteoarthritis
,
chronic renal insufficiency
,
infections
,
respiratory insufficiency
,
communicable diseases
,
collagen diseases
,
coronary disease
,
atrial flutter
,
thrombophlebitis
,
atrial fibrillation
,
thromboembolism
,
venous thromboembolism
,
thrombosis
,
embolism
,
pulmonary embolism
,
stroke
,
hemorrhage
,
peripheral arterial disease
,
coronary artery disease
,
covid-19
,
cardiovascular diseases
,
syndrome
,
atherosclerosis
,
respiratory tract diseases
,
embolism and thrombosis
,
lung diseases
,
emergencies
,
antiphospholipid syndrome
,
calcinosis
,
intermittent claudication
,
inflammation
,
carotid stenosis
,
peripheral vascular diseases
,
atherosclerotic plaque
,
replacement arthroplasty hip
,
intracranial hemorrhages
,
disease progression
,
brain ischemia
,
bronchiectasis
,
congenital heart defects
,
fontan procedure
Mevalotin
hypertriglyceridemia
,
cardiovascular diseases
Evidence
neoplasms
,
multiple myeloma
,
lymphoma
,
plasma cell neoplasms
,
large b-cell lymphoma diffuse
,
castration-resistant prostatic neoplasms
,
colorectal neoplasms
,
esophageal neoplasms
,
adenocarcinoma
,
breast neoplasms
,
non-small-cell lung carcinoma
,
carcinoma
,
triple negative breast neoplasms
,
melanoma
,
hiv-1
,
glioma
,
squamous cell carcinoma
,
squamous cell neoplasms
,
penile neoplasms
,
myelodysplastic syndromes
,
myelomonocytic leukemia chronic
,
myelomonocytic leukemia juvenile
,
preleukemia
,
syndrome
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
infections
,
communicable diseases
,
prostatic neoplasms
,
soft tissue infections
,
leukemia
,
myeloid leukemia acute
,
glioblastoma
,
ischemic stroke
,
stroke
,
myeloid leukemia
,
heart diseases
,
coronary artery disease
,
myocardial ischemia
,
hypertension
,
pulmonary hypertension
,
fibrosis
,
lung diseases
,
pulmonary arterial hypertension
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
interstitial lung diseases
,
ischemia
,
chest pain
,
coronary disease
,
covid-19
,
atrial fibrillation
,
respiratory syncytial viruses
,
lung neoplasms
,
sars-cov-2
,
immunocompromised host
,
breakthrough infections
,
thrombosis
,
rheumatoid arthritis
,
arthritis
,
renal cell carcinoma
,
kidney neoplasms
,
cardiovascular diseases
,
ulcerative colitis
,
crohn disease
,
colitis
,
ulcer
,
pain
,
chronic pain
,
lymphedema
,
dementia
,
nerve degeneration
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
respiratory tract infections
,
virus diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use